These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 6487466)

  • 1. Antipyrine absorption after delayed oesophageal capsule transit.
    Channer KS; Roberts CJ
    Br J Clin Pharmacol; 1984 Aug; 18(2):250-3. PubMed ID: 6487466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of left atrial size on the oesophageal transit of capsules.
    Channer KS; Bell J; Virjee JP
    Br Heart J; 1984 Aug; 52(2):223-7. PubMed ID: 6234911
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impaired oesophageal transit of capsule versus tablet formulations in the elderly.
    Perkins AC; Wilson CG; Blackshaw PE; Vincent RM; Dansereau RJ; Juhlin KD; Bekker PJ; Spiller RC
    Gut; 1994 Oct; 35(10):1363-7. PubMed ID: 7959187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oesophageal function tests: are they of value?
    Channer KS; Virjee JP
    Clin Radiol; 1985 Sep; 36(5):493-6. PubMed ID: 4075719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors influencing the transit of a gelatin capsule in the esophagus.
    Bailey RT; Bonavina L; McChesney L; Spires KJ; Muilenburg MI; McGill JE; DeMeester TR
    Drug Intell Clin Pharm; 1987 Mar; 21(3):282-5. PubMed ID: 3569029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of formulation on oesophageal transit.
    Channer KS; Virjee JP
    J Pharm Pharmacol; 1985 Feb; 37(2):126-9. PubMed ID: 2858546
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of hyoscine butylbromide on the swallowing of capsules.
    Channer KS; Wolinski A; Kaye B; Virjee J
    Br J Clin Pharmacol; 1983 May; 15(5):560-3. PubMed ID: 6860531
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of food intake on the delivery of fluorescein as a model drug in colon delivery capsule after oral administration to beagle dogs.
    Matsuda K; Takaya T; Shimoji F; Muraoka M; Yoshikawa Y; Takada K
    J Drug Target; 1996; 4(2):59-67. PubMed ID: 8894965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of delayed esophageal transit on acetaminophen absorption.
    Channer KS; Roberts CJ
    Clin Pharmacol Ther; 1985 Jan; 37(1):72-6. PubMed ID: 3965238
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Excipient effects on gastrointestinal transit and drug absorption in beagle dogs.
    Schulze JD; Peters EE; Vickers AW; Staton JS; Coffin MD; Parsons GE; Basit AW
    Int J Pharm; 2005 Aug; 300(1-2):67-75. PubMed ID: 15979264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antipyrine repeatability and comparison of the powder and capsule formulations.
    Edeki T; Turner P
    Int J Clin Pharmacol Ther; 1995 Feb; 33(2):70-5. PubMed ID: 7757313
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics of methylphenidate after oral administration of two modified-release formulations in healthy adults.
    Markowitz JS; Straughn AB; Patrick KS; DeVane CL; Pestreich L; Lee J; Wang Y; Muniz R
    Clin Pharmacokinet; 2003; 42(4):393-401. PubMed ID: 12648029
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dynamics of capsule swallowing by healthy young men and capsule transit time from the mouth to the stomach.
    Chisaka H; Matsushima Y; Wada F; Saeki S; Hachisuka K
    Dysphagia; 2006 Oct; 21(4):275-9. PubMed ID: 17216387
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A pharmacokinetic analysis of diclofenac potassium soft-gelatin capsule in patients after bunionectomy.
    Kowalski M; Stoker DG; Bon C; Moore KA; Boesing SE
    Am J Ther; 2010; 17(5):460-8. PubMed ID: 19531931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of the gastrointestinal transit and disintegration behavior of floating and sinking acid-resistant capsules using a novel MRI labeling technique.
    Grimm M; Ball K; Scholz E; Schneider F; Sivert A; Benameur H; Kromrey ML; Kühn JP; Weitschies W
    Eur J Pharm Sci; 2019 Mar; 129():163-172. PubMed ID: 30639530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of nifedipine absorption from soft gelatin capsules using PBPK modeling and biorelevant dissolution testing.
    Thelen K; Jantratid E; Dressman JB; Lippert J; Willmann S
    J Pharm Sci; 2010 Jun; 99(6):2899-904. PubMed ID: 20014280
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Esophageal passage of iodine-131 capsules.
    Garcia-Peña E; Caravalho J; Watkins JW; Leifer ES
    J Nucl Med Technol; 1997 Mar; 25(1):55-8. PubMed ID: 9239606
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Scintigraphic verification of adherence of a chitosan formulation to the human oesophagus.
    Säkkinen M; Marvola J; Kanerva H; Lindevall K; Ahonen A; Marvola M
    Eur J Pharm Biopharm; 2004 Jan; 57(1):145-7. PubMed ID: 14729090
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Magnetic marker monitoring of esophageal, gastric and duodenal transit of non-disintegrating capsules.
    Weitschies W; Cardini D; Karaus M; Trahms L; Semmler W
    Pharmazie; 1999 Jun; 54(6):426-30. PubMed ID: 10399189
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oesophageal transit of six commonly used tablets and capsules.
    Hey H; Jørgensen F; Sørensen K; Hasselbalch H; Wamberg T
    Br Med J (Clin Res Ed); 1982 Dec; 285(6356):1717-9. PubMed ID: 6816343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.